| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.9M | — | -2.9% |
| Cost of Revenue | $4.8M | — | +54.7% |
| R&D Expense | $961K | — | +58.6% |
| SG&A Expense | $2.4M | — | -25.4% |
| Operating Income | -$3.5M | — | -150.1% |
| Pre-tax Income | -$3.3M | — | -197.9% |
| Income Tax | $30K | — | +306.1% |
| Net Income | -$3.4M | — | -198.6% |
| EPS (Basic) | -$0.11 | — | -175.0% |
| EPS (Diluted) | -$0.11 | — | -175.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.0M | +139.9% | +442.6% |
| Short-term Investments | $0 | -100.0% | -100.0% |
| Accounts Receivable | $3.0M | -46.5% | -42.2% |
| Current Assets | $37.4M | -12.1% | -19.3% |
| Total Assets | $38.8M | -12.0% | -20.1% |
| Current Liabilities | $11.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$548K | — | -222.3% |
| Investing Cash Flow | $18.7M | — | +2128.1% |
| Financing Cash Flow | -$79K | — | +54.4% |
| -35.7% |
| Total Liabilities | $11.9M | -16.9% | -35.7% |
| Stockholders' Equity | $26.9M | -9.7% | -10.5% |